膜曝气生物膜反应器市场 - 全球产业规模、份额、趋势、机会、预测：按类型、应用、处理能力、地区和竞争对手划分，2021-2031年

全球膜曝气生物膜反应器市场预计将从 2025 年的 18.6 亿美元成长到 2031 年的 25.9 亿美元，复合年增长率为 5.67%。

这种生物污水处理技术利用渗透性膜直接向生物膜供氧，从而在单一反应器内实现硝化和反硝化同步进行。透过采用无气泡曝气，其氧气传输效率远高于传统的扩散技术。该领域的发展主要受日益严格的营养物去除法规以及老旧设施维修的需求所驱动，旨在提高处理能力的同时，又不增加面积。此外，业界为实现能源中和所做的努力也加速了该技术的应用，并且这些系统透过改进曝气机制显着降低了营运成本。

然而，专用膜组件所需的大量初始投资，以及长期生物膜控制和污垢管理方面的技术挑战，阻碍了市场的广泛扩张。这些维护要求对于缺乏先进技术能力的小规模市政当局来说可能构成障碍。儘管有这些挑战，但其高运作效率仍是公共产业事业的一大优势。根据国际水协会 (IWA) 2024 年的报告，与传统的活性污泥法相比，薄膜生物反应器 (MABR) 技术可将曝气能耗降低高达 50%，并已成为永续城市水资源管理策略的关键组成部分。

市场驱动因素

更新和维修老旧基础设施的需求是推动成长的重要因素。主要原因是膜生物反应器（MABR）技术能够在现有处理池内提升处理能力。这种「即插即用」的特性对于那些缺乏空间和资金开展新土木工程项目，同时又面临严格营养物排放法规的市政当局至关重要。透过将膜组件直接悬挂在现有的厌氧区，操作人员可以同时维持硝化生物膜和悬浮污泥，从而显着提高处理性能。例如，正如WaterProjectsOnline在2024年12月报导的那样，塞文特伦特水务公司（Severn Trent Water）的蒙克穆尔（Monkmoor）污水处理厂维修使用了48个OxyMem MABR组件，实现了每日243公斤氮当量的氨去除率，超过设计了162公斤的目标。

同时，快速的都市化和不断扩张的工业活动正在推动相关技术的应用，高负荷的製造工厂需要高效的复杂废水处理方案。食品加工和造纸等行业越来越多地使用此类反应器来处理高浓度污水，同时满足环保标准。 Fluence 公司在 2024 年 3 月订单了义大利一家再生纸厂价值 230 万美元的订单，为其建造一座日处理量 7500 立方米的 MABR 装置，这充分体现了市场对 MABR 的强劲需求。这种市场动能也体现在区域采购绩效。 Fluence 公司在 2024 年 3 月报告称，其在北美地区的前两个月订单达到 330 万美元，超过了去年在该地区的总销售额。

市场挑战

专用膜组件所需的大量前期投资是膜曝气生物膜反应器（MABR）技术广泛应用的主要障碍。虽然该系统能够长期节省营运成本，但这些先进曝气设备的前期投资远高于传统曝气器。生物膜厚度控制和污染预防的技术复杂性进一步加剧了这项财务挑战。这些工作需要熟练的人员和严格的维护程序，而小规模公共工程项目往往缺乏这些条件。因此，儘管预期未来效率将即时提升，但出于规避风险的考虑，市政领导常常以购买和培训成本为由，推迟升级到这种更有效率的系统。

全球水务产业普遍面临的财务压力进一步加剧了这种不情愿。在预算限制下，支持高端基础建设支出变得困难重重。国际水协会（IWA）指出，2024年，在受调查的全球城市中，三分之一城市的污水处理相关环境费用将占总水费的50%以上。这一数字凸显了供水事业预算面临的巨大压力，直接限制了他们承担部署先进膜生物反应器（MABR）基础设施相关高昂成本的能力。这种财务限制实际上阻碍了市场成长，因为只有资金雄厚的供水事业才能参与其中。

市场趋势

模组化和货柜式膜生物反应器（MABR）装置的兴起正在改变市场格局，为分散式应用提供灵活的即插即用处理方案。与需要大规模土木工程的集中式系统不同，这些预包装解决方案使市政当局和私人开发商能够在偏远或空间受限的地区快速建立生物处理能力。这种供应方式显着缩短了安装时间和初始建造成本，即使在资金有限的小规模社区和商业计划中，也能实现高效的营养物去除。该领域的商业性成功持续成长。根据Fluence公司2024年4月发布的季度活动报告，其智慧产品解决方案部门（包括模组化MABR产品）第一季的销售额较去年同期成长了50%。

同时，随着全球水务产业聚焦净零排放目标，市场正稳步向能源中和、低碳营运模式转型。公共事业公司越来越多地选择膜生物反应器（MABR）技术，不仅是为了满足监管要求，更是为了将其视为一项战略资产，以将污水处理与高电力消耗及其产生的碳足迹脱钩。这些系统采用被动曝气膜，无需高能耗鼓风机，显着降低了范围2排放，并透过其长期永续性优势证明了高额投资的合理性。大型公共产业的支出趋势也反映了这个策略方向。根据《水务业杂誌》2024年3月报道，塞文特伦特水务公司投资620万英镑升级其蒙克穆尔MABR设施，旨在使其先进处理能力与其更广泛的碳减排目标保持一致。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球膜曝气生物膜反应器市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（模组化、货柜式、混凝土搅拌站）
  • 透过申请（适用于地方政府、产业）
  • 依类别分類的处理能力（1立方公尺/天至50立方公尺/天，50立方公尺/天至150立方公尺/天，150立方公尺/天至500立方公尺/天，超过500立方公尺/天）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美膜曝气生物膜反应器市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲膜曝气生物膜反应器市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区膜曝气生物膜反应器市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲膜曝气生物膜反应器市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美膜曝气生物膜反应器市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球膜曝气生物膜反应器市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Xylem Inc.
• Pentair plc
• Aqua-Aerobic Systems, Inc.
• EnviroChemie GmbH
• BASF SE
• Emerson Electric Co.
• ITT Inc.
• Tetra Tech, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Membrane Aerated Biofilm Reactor Market is projected to expand from USD 1.86 Billion in 2025 to USD 2.59 Billion by 2031, reflecting a compound annual growth rate of 5.67%. This biological wastewater treatment method leverages gas-permeable membranes to supply oxygen directly to a biofilm, facilitating simultaneous nitrification and denitrification within a single reactor. By utilizing bubble-free aeration, the process achieves superior oxygen transfer efficiency relative to traditional diffusion techniques. Growth in this sector is primarily fueled by stricter nutrient removal mandates and the need to retrofit aging facilities to boost capacity without enlarging their physical footprint. Additionally, the industry's push toward energy neutrality fosters adoption, as these systems provide significant operational cost savings through enhanced aeration mechanics.

However, broad market expansion is hindered by the substantial initial capital investment needed for specialized membrane modules and the technical difficulties involved in long-term biofilm control and fouling management. These maintenance requirements can be a deterrent for smaller municipalities lacking extensive technical capabilities. Despite these obstacles, operational efficiency remains a compelling advantage for utility operators. According to the International Water Association's 2024 report, MABR technology can lower aeration energy usage by as much as 50% compared to conventional activated sludge systems, establishing it as a vital element in sustainable urban water management strategies.

Market Driver

The necessity to upgrade and retrofit aging infrastructure acts as a primary catalyst for growth, largely because MABR technology enables utilities to increase treatment capacity within existing basin boundaries. This "drop-in" functionality is crucial for municipalities encountering rigorous nutrient discharge regulations yet lacking the space or funds for new civil construction. By suspending membrane modules directly into existing anoxic zones, operators can support both nitrifying biofilms and suspended sludge, leading to marked performance improvements. For example, WaterProjectsOnline noted in December 2024 that the retrofit of Severn Trent Water's Monkmoor Sewage Treatment Works, using 48 OxyMem MABR modules, achieved an ammonia removal rate of 243 kilograms of nitrogen daily, exceeding the design target of 162 kilograms.

Concurrently, rapid urbanization and expanding industrial activities are driving adoption, as high-load manufacturing plants require effective solutions for complex effluents. Industries such as food processing and paper manufacturing are increasingly utilizing these reactors to manage high-strength wastewater while meeting environmental standards. Fluence Corporation highlighted this demand in March 2024 by securing a $2.3 million contract for a 7,500 cubic meter per day MABR plant at an Italian recycled paper mill. The market momentum generated by these factors is reflected in regional procurement figures; Fluence Corporation reported in March 2024 that it secured $3.3 million in North American municipal bookings during the first two months of the year, surpassing the region's total sales for the previous year.

Market Challenge

The substantial initial capital outlay required for specialized membrane modules poses a significant obstacle to the widespread implementation of Membrane Aerated Biofilm Reactor technology. Although the system offers long-term operational cost reductions, the upfront investment for these advanced aeration units is considerably higher than that for traditional diffusers. This financial challenge is exacerbated by the technical complexities involved in managing biofilm thickness and mitigating fouling, tasks that demand skilled staff and strict maintenance routines often missing in smaller utility operations. As a result, risk-averse municipal leaders frequently postpone upgrading to this efficient architecture, considering the immediate acquisition and training expenses to be prohibitive despite the promise of future efficiency enhancements.

This reluctance is further entrenched by the general financial stress impacting the global water sector, where constrained budgets struggle to support premium infrastructure spending. According to the International Water Association, in 2024, environmental fees related to wastewater treatment constituted more than 50% of the total water bill in one-third of cities surveyed globally. This figure highlights the severe pressure on utility budgets, which directly restricts the fiscal ability of operators to bear the high costs linked to deploying advanced MABR infrastructure. Such financial limitations effectively impede market growth by limiting access to only the most well-funded utility providers.

Market Trends

The rise of modular and containerized MABR units is transforming the market by offering flexible, plug-and-play treatment options for decentralized uses. Unlike centralized systems that demand extensive civil engineering, these pre-packaged solutions enable municipalities and private developers to quickly establish biological treatment capacity in remote or space-limited areas. This delivery approach drastically cuts installation times and upfront construction expenses, making high-performance nutrient removal attainable for smaller communities and commercial projects lacking the funds for custom facilities. The commercial success of this sector is growing; Fluence Corporation's April 2024 'Quarterly Activities Report' noted that its Smart Product Solutions division, which houses its modular MABR line, saw a 50% revenue jump in the first quarter compared to the same period the prior year.

At the same time, the market is moving decisively toward energy-neutral and low-carbon operations, motivated by the global water sector's dedication to net-zero emission goals. Utilities are increasingly selecting MABR technology not merely for regulatory compliance, but as a strategic asset to disconnect wastewater treatment from high electricity usage and the resulting carbon footprints. By employing passive aeration membranes that remove the need for energy-consuming blowers, these systems substantially reduce Scope 2 emissions, warranting premium investments through long-term sustainability benefits. This strategic direction is clear in major utility spending; as reported by Water Industry Journal in March 2024, Severn Trent Water allocated £6.2 million for the Monkmoor MABR upgrade specifically to align the plant's enhanced treatment capacity with the company's wider carbon reduction objectives.

Key Market Players

• Xylem Inc.
• Pentair plc
• Aqua-Aerobic Systems, Inc.
• EnviroChemie GmbH
• BASF SE
• Emerson Electric Co.
• ITT Inc.
• Tetra Tech, Inc.

Report Scope

In this report, the Global Membrane Aerated Biofilm Reactor Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Membrane Aerated Biofilm Reactor Market, By Type

• Modules
• Containerized
• Concrete Plants

Membrane Aerated Biofilm Reactor Market, By Application

• Municipal
• Industrial

Membrane Aerated Biofilm Reactor Market, By Treatment Capacity

• 1 m3/d - 50 m3/d
• 50 m3/d - 150 m3/d
• 150 m3/d - 500 m3/d
• Above 500 m3/d

Membrane Aerated Biofilm Reactor Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Membrane Aerated Biofilm Reactor Market.

Available Customizations:

Global Membrane Aerated Biofilm Reactor Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Membrane Aerated Biofilm Reactor Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Modules, Containerized, Concrete Plants)
  • 5.2.2. By Application (Municipal, Industrial)
  • 5.2.3. By Treatment Capacity (1 m3/d - 50 m3/d, 50 m3/d - 150 m3/d, 150 m3/d - 500 m3/d, Above 500 m3/d)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Membrane Aerated Biofilm Reactor Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Treatment Capacity
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Membrane Aerated Biofilm Reactor Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Treatment Capacity
  • 6.3.2. Canada Membrane Aerated Biofilm Reactor Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Treatment Capacity
  • 6.3.3. Mexico Membrane Aerated Biofilm Reactor Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Treatment Capacity

7. Europe Membrane Aerated Biofilm Reactor Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Treatment Capacity
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Treatment Capacity
  • 7.3.2. France Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Treatment Capacity
  • 7.3.3. United Kingdom Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Treatment Capacity
  • 7.3.4. Italy Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Treatment Capacity
  • 7.3.5. Spain Membrane Aerated Biofilm Reactor Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Treatment Capacity

8. Asia Pacific Membrane Aerated Biofilm Reactor Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Treatment Capacity
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Treatment Capacity
  • 8.3.2. India Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Treatment Capacity
  • 8.3.3. Japan Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Treatment Capacity
  • 8.3.4. South Korea Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Treatment Capacity
  • 8.3.5. Australia Membrane Aerated Biofilm Reactor Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Treatment Capacity

9. Middle East & Africa Membrane Aerated Biofilm Reactor Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Treatment Capacity
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Membrane Aerated Biofilm Reactor Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Treatment Capacity
  • 9.3.2. UAE Membrane Aerated Biofilm Reactor Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Treatment Capacity
  • 9.3.3. South Africa Membrane Aerated Biofilm Reactor Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Treatment Capacity

10. South America Membrane Aerated Biofilm Reactor Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Treatment Capacity
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Membrane Aerated Biofilm Reactor Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Treatment Capacity
  • 10.3.2. Colombia Membrane Aerated Biofilm Reactor Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Treatment Capacity
  • 10.3.3. Argentina Membrane Aerated Biofilm Reactor Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Treatment Capacity

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Membrane Aerated Biofilm Reactor Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Xylem Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Pentair plc
• 15.3. Aqua-Aerobic Systems, Inc.
• 15.4. EnviroChemie GmbH
• 15.5. BASF SE
• 15.6. Emerson Electric Co.
• 15.7. ITT Inc.
• 15.8. Tetra Tech, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer